EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Prognostic Factors and Regulatory Pathways in Porto‐Sinusoidal Vascular Disorder

Subin Heo iD, Do Kyung Yoon, Soyeon Shin, Dami Youn, Youngeun Yoo iD, In Hye Song iD, Hyo Jeong Kang iD, Young-In Yoon iD, Kyunggon Kim iD, Seung Soo Lee iD, Sung Won Chung iD, Jonggi Choi iD und 8 weitere

Liver International · 2026-11 · 46 (11)

DOI: 10.1111/liv.70898 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 30.09.2026. Verfasst von Subin Heo und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health & Welfare, Republic of Korea, Korean Association for the Study of the Liver, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Porto‐sinusoidal vascular disorder (PSVD) is a rare liver condition characterized by specific histological features primarily affecting the hepatic sinusoidal and periportal vasculature, in the absence of cirrhosis. This study aimed to identify prognostic factors and regulatory pathways associated with PSVD by integrating transcriptomic and clinical data.

Methods

A total of 114 PSVD patients were included, with 74 followed longitudinally for liver‐related events. RNA sequencing was performed on 21 liver samples and compared to six histologically normal livers. Associations between clinical parameters, such as liver‐to‐spleen volume ratio (LSVR) and fibrosis stage, with liver‐related events were assessed. Transcriptomic analyses, including co‐expression and cell deconvolution, were conducted based on these parameters.

Results

Among the 114 patients, 32 (28.1%) underwent liver transplantation at diagnosis. LSVR strongly correlated with fibrosis stage, which was significantly associated with liver transplantation (per 1‐stage increase: adjusted OR, 14.88; 95% CI: 3.72–59.58). Over a mean follow‐up of 6.7 years in the longitudinal cohort, 12 patients (16.2%) experienced liver‐related events. LSVR was identified as a significant prognostic marker, with an optimal cut‐off value of 1.33 for predicting liver‐related events. Transcriptomic analysis based on LSVR and fibrosis stage revealed distinct gene expression patterns and cellular changes in PSVD, including shifts in liver sinusoidal endothelial cell (LSEC) distribution, an increased hepatic stellate cell population, and upregulation of IL‐6 signalling, without changes in immune cell composition as the disease progresses.

Conclusions

This study identified LSVR as a novel prognostic marker in PSVD and suggests that IL‐6 trans‐signalling‐induced endotheliopathy in LSECs may play a role in the proinflammatory and fibrotic changes associated with disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiverHumansFemalePrognosisMaleMiddle AgedIdiopathic Noncirrhotic Portal HypertensionLiver TransplantationLiver CirrhosisGene Expression ProfilingTranscriptomeInterleukin-6Longitudinal Studies

Stichwörter der Autor:innen

IL‐6Noncirrhotic portal fibrosisliver‐to‐spleen volume ratiotranscriptomic analysis

Substanzen

Interleukin-6

Autor:innen und Institutionen

  • Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Biochemistry and Molecular Biology, Brain Korea 21 Project, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Department of Pathology, Ewha Womans University College of Medicine, Seoul, Korea.
  • Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

ORCID-Profile: Subin Heo, Youngeun Yoo, In Hye Song, Hyo Jeong Kang, Young-In Yoon, Kyunggon Kim, Seung Soo Lee, Sung Won Chung, Jonggi Choi, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Ho-Su Lee, Won-Mook Choi

Förderung

  • Ministry of Health & Welfare, Republic of Korea
  • Korean Association for the Study of the Liver
  • National Research Foundation of Korea
  • Medical Research Center (MRC)
  • ACL HHS
  • Asan Institute for Life Sciences and Corporate Relations of Asan Medical Center

Zitieren

APA

Heo, S., Yoon, D. K., Shin, S., Youn, D., Yoo, Y., Song, I. H., Kang, H. J., Yoon, Y. I., Kim, K., Lee, S. S., Chung, S. W., Choi, J., Lee, D., Shim, J. H., Kim, K. M., Lim, Y. S., Lee, H. C., Muthiah, M., Lee, H. S., & Choi, W. M. (2026). Identification of Prognostic Factors and Regulatory Pathways in Porto‐Sinusoidal Vascular Disorder. Liver International, 46(11). https://doi.org/10.1111/liv.70898

Vancouver

Heo S, Yoon DK, Shin S, Youn D, Yoo Y, Song IH, et al. Identification of Prognostic Factors and Regulatory Pathways in Porto‐Sinusoidal Vascular Disorder. Liver International. 2026;46(11). doi:10.1111/liv.70898

BibTeX
@article{Heo2026,
  author = {Heo, Subin and Yoon, Do Kyung and Shin, Soyeon and Youn, Dami and Yoo, Youngeun and Song, In Hye and Kang, Hyo Jeong and Yoon, Young-In and Kim, Kyunggon and Lee, Seung Soo and Chung, Sung Won and Choi, Jonggi and Lee, Danbi and Shim, Ju Hyun and Kim, Kang Mo and Lim, Young-Suk and Lee, Han Chu and Muthiah, Mark and Lee, Ho-Su and Choi, Won-Mook},
  title = {Identification of Prognostic Factors and Regulatory Pathways in Porto‐Sinusoidal Vascular Disorder},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {11},
  doi = {10.1111/liv.70898}
}
Kostenlos starten →